Future of Pharmacy

At the ASHP Pharmacy Futures 2024 conference, Scott D. Nelson, PharmD, MS, ACHIP, FAMIA, discusses research showed that although AI models can significantly enhance diagnostic accuracy, they can also exacerbate existing disparities.

Kenneth A. Richman, PhD, discusses the disruptive nature of artificial intelligence (AI) in health care, highlighting both its transformative potential and the ethical considerations of governability and sustainability in its implementation.

With its ability to decode genetic variations influencing drug response, pharmacogenomics holds immense promise in reshaping health care delivery.

By venturing beyond the traditional, you can not only shape your own fulfilling career, but also contribute to the future of pharmacy practice and improve patient care for generations to come.

Scott Soefje highlights how oncology pharmacists can advance patient-centered care and drive innovation in clinical research.

With worsening news from accounting, where does community pharmacy go from here?

Notable contributions from female leaders in the pharmaceutical industry demonstrate the exceptional competence of women in vaccine innovation.

AI offers many benefits in health professions by efficiently handling time-consuming tasks crucial for patient care.

Integrate nutrition into the health care system with a proactive approach to chronic disease management

In the State of the Union Address, President Biden said he wants to expand the $2,000 out-of-pocket cap beyond seniors and allow Medicare to negotiate more costly drugs.

There is a growing number of technologies, processes, and treatments being discovered in the quest to extend life.

Up-front payments to pharmacies will be significantly lower starting this year, creating cash flow challenges

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discusses the multifaceted role of oncology pharmacists in diverse care settings, emphasizing their collaboration in treatment decisions and adaption in the evolving landscape of cancer care.

The co-founders of PPA discuss the importance of advocacy work at this point in the development of the psychedelic medicine industry to help cement pharmacist’s role in the continuum of care.

WIth 31% of the US population living in a health care provider shortage area, current bills in Congress look to broaden the scope of pharmacists’ role in patient care.

To develop the next generation of pharmacy leaders, pharmacists should receive effective training from the beginning of their careers.

In the pharmacy, time is the ultimate value-add.

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Noha Aboelata, MD to discuss her journey opening clinics and importance of health equity.

Tom Kraus, JD discusses current federal regulatory and legislative issues that impact the practice of health-system pharmacy.

Kirollos Hanna, PharmD, BCPS, BCOP, FACC, discusses the multifaceted involvement of oncology pharmacists in various aspects of patient care.

It is crucial to continue to evolve from dependent prescribing to an independent model, and address barriers with opportunities for change.

Calvin Tucker, PharmD, MBA, FCCM, FFSHP, Pharmacy Manager for the Cancer Care Pharmacy discusses the unique and valuable role pharmacist have within the health care community

A well-executed, human-like digital relationship can transform patient engagement to patient activation.

Amber Bush, PharmD, RPh, BCPS, BCCCP, pharmacy research coordinator for Mayo Clinic discusses the future of pharmacy through her role within research clinical trials

RFID technology encompass a wide range of applications, including inventory management, medication authentication, patient adherence, and workflow efficiency.

Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP, discusses SDOH and how pharmacists, particularly within community pharmacies, are the most accessible health care providers and can play a crucial role in advocating for patients.

Grace Yun, PharmD, and pharmacy manager at St. Francis Hospital, discussed the value of the pharmacist and how she sees the future of pharmacy evolving.

Although all legislation is currently on hold in Congress, there are important actions under consideration for pharmacy, including digital therapeutics, access to care, and health care disparities.

The committee will help the FDA address issues related to digital health technologies, including artificial intelligence, virtual reality, cyber security, and patient-generated health data.

Laura Akers, PharmD, RPh/CPh, MBA, BCOP discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.